Sign in

You're signed outSign in or to get full access.

2C

22nd Century Group, Inc. (XXII)·Q2 2015 Earnings Summary

Executive Summary

  • Q2 2015 showed a sharp revenue ramp as XXII scaled manufacturing and recorded initial MAGIC sales in Europe: revenue $2.307M vs $0.016M in Q2 2014 and $0.616M in Q1 2015; net loss improved to $(1.29)M (or $(0.02) per share) helped by a $1.0M litigation settlement, offset by gross loss from underutilized factory capacity .
  • Revenues exceeded management’s prior Q2 expectation of “in excess of $1.5M” and the company maintained FY2015 revenue guidance of “more than $5 million” (Q1 phrasing: “substantially more than $5 million”), a key potential stock catalyst for micro-cap coverage expansion and execution narrative .
  • Gross margin was negative (COGS 112.7% of sales) due to fixed-cost absorption from underutilized capacity; operating loss was $(2.35)M, while Adjusted EBITDA was $(1.80)M vs $(0.85)M YoY, reflecting higher sales and marketing and scale-up costs .
  • Strategic progress: RED SUN achieved approvals in all 50 states; MAGIC launched in Spain with initial UK rollout delayed to fall due to required label changes; the company advanced MRTP plans for very low nicotine cigarettes with a targeted submission in fall 2015 .

What Went Well and What Went Wrong

What Went Well

  • Revenue execution beat internal expectations: Q2 revenue $2.307M exceeded the company’s prior guide of >$1.5M, with contributions from RED SUN, third‑party MSA brand manufacturing, filtered cigars, and initial MAGIC sales in Europe .
  • Commercial milestones: “We successfully obtained approval from all 50 states to sell our RED SUN super-premium cigarette brand across the country,” supporting broader U.S. distribution and consumer marketing programs .
  • Pipeline and IP: The company “dramatically increased [its] intellectual property portfolio,” now “more than 185 issued patents and more than an additional 54 pending,” and prepared to submit MRTP for very low nicotine BRAND A in fall 2015, positioning regulatory differentiation .

What Went Wrong

  • Margin pressure from underutilization: COGS were 112.7% of sales (gross margin approximately −12.7%) as fixed factory costs outweighed volumes; operating loss was $(2.35)M despite revenue growth .
  • MAGIC UK timing slippage: UK introduction, initially intended for June, was postponed to fall due to required changes in consumer warning labels, modestly delaying European expansion .
  • Higher operating spend: Sales and marketing rose to $0.291M in Q2 (vs $0.034M YoY) to support RED SUN and MAGIC launches; general and administrative costs remained elevated with factory-related expense, contributing to negative Adjusted EBITDA $(1.80)M vs $(0.85)M YoY .

Financial Results

P&L summary (oldest → newest):

MetricQ2 2014Q1 2015Q2 2015
Revenue ($)$16,114 $616,000 $2,306,953
Gross Profit (Loss) ($)$2,938 N/A$(293,493)
COGS as % of Revenue81.8% N/A112.7%
Operating Loss ($)$(2,038,163) $(4,100,000) (reported) $(2,346,736)
Net Loss ($)$(1,965,815) $(4,116,739) $(1,288,703)
Diluted EPS ($)$(0.03) $(0.06) $(0.02)
Adjusted EBITDA ($)$(845,073) $(1,517,367) $(1,800,746)
Other Income (Litigation) ($)$0 $0 $1,000,000

Estimates vs Actuals (Q2 2015):

MetricConsensusActualSurprise
Revenue ($)N/A (SPGI consensus unavailable)$2,306,953 N/A
EPS ($)N/A (SPGI consensus unavailable)$(0.02) N/A

KPIs and Balance Sheet (as of/for Q2 2015):

KPIValueContext
MAGIC retail locations (Spain)~1,137 stores (as of early May) European launch underway
RED SUN state approvals50 states U.S. distribution enabled
Cash and Cash Equivalents$8,196,739 Cash at 6/30/2015
Working Capital~$9.2M Positive working capital
Net Cash Used in Operations (YTD)$(3,604,029) 1H15 operating cash use
Shares Outstanding (as of 8/4/2015)70,873,164 Post Q2 issuance

Segment/driver commentary:

  • Revenue drivers: third‑party MSA cigarette brand manufacturing, filtered cigars, RED SUN proprietary brand, initial MAGIC sales in Europe .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
RevenueQ2 2015“In excess of $1.5M” (Q1 guidance) Actual $2.307M Beat prior expectation
RevenueFY 2015“Substantially more than $5 million” (Q1) “More than $5 million” (Q2) Maintained (language slightly nuanced)

No other formal guidance (margins, OpEx, tax, etc.) was provided in the Q2 press release or 10‑Q .

Earnings Call Themes & Trends

Note: A Q2 2015 call was held Aug 5, 2015, but a transcript was not available via our sources; themes below reflect Q1 and Q2 disclosures .

TopicQ-2 (Q4 2014)Q-1 (Q1 2015)Current (Q2 2015)Trend
Regulatory/MRTPN/A“On schedule” to submit very low nicotine modified risk application in summer 2015 Targeting BRAND A MRTP submission in fall 2015; BRAND B in 2016 subject to funding Continued progress, timeline shifted to fall
Product launches (MAGIC)N/ASpain launch live; ~1,137 stores; plan to expand to UK/France/Italy/Belgium in coming months Spain ongoing; UK/NL/Italy/France launch postponed to fall due to label changes Execution with UK timing delay
U.S. brand (RED SUN)N/AApproved in 49 states; consumer marketing planned Approved in all 50 states; ambassador program and consumer promotions underway Broader footprint and marketing
Manufacturing utilizationN/AFactory producing third‑party MSA brand, filtered cigars, RED SUN Underutilization causing gross loss; scaling contract manufacturing base Utilization improving but still below breakeven
Partnerships/AsiaN/APursuing JV for X‑22; exploring opportunities in China/Korea/Japan Continuing JV efforts incl. Asia; optimistic on 2015 contracts Ongoing dialogue

Management Commentary

  • “Revenues during the second quarter of 2015, in the amount of $2,307,000, exceeded previously announced revenue expectations of $1,500,000…” .
  • “We successfully obtained approval from all 50 states to sell our RED SUN super-premium cigarette brand across the country.” .
  • “We now intend to submit to the FDA in the fall of 2015 a completed application for our proprietary BRAND A very low nicotine tobacco cigarettes.” .
  • “We successfully launched MAGIC, the world’s only ‘0.0mg nicotine’ tobacco cigarette brand, in more than 900 state-licensed retail shops in Spain in April 2015.” ; “As of late last week, MAGIC cigarettes are available… at approximately 1,137 retail shops across Spain.” .

Q&A Highlights

  • A conference call was held on August 5, 2015; however, no public transcript was available through our sources. As a result, we cannot provide Q&A highlights or any guidance clarifications beyond the press release and 10‑Q disclosures .

Estimates Context

  • Wall Street consensus estimates from S&P Global (EPS and revenue) for Q2 2015 were not retrievable due to access limits; given the company’s size, coverage may be limited. Therefore, comparisons to consensus could not be provided. We benchmarked actuals against management’s disclosed expectations instead (Q2 revenue guide >$1.5M, actual $2.307M) .

Key Takeaways for Investors

  • Execution improving: Material revenue inflection ($2.31M) with diversified drivers (own brands + contract manufacturing) and a clear beat vs internal expectations; watch for sustained sequential growth in H2 2015 as utilization increases .
  • Margins remain the swing factor: Gross losses stem from fixed-cost absorption at the factory; incremental volumes (new contracts/brand growth) are key to moving COGS below revenue and driving operating leverage .
  • Near-term catalysts: Fall 2015 MRTP submission for very low nicotine cigarettes (BRAND A) and resumed UK/EU MAGIC rollout after label revisions; any Asia JV announcements would further validate strategy .
  • Marketing scale-up: RED SUN now 50‑state approved with consumer-facing campaigns; spending is rising, but could accelerate brand trials and distribution—monitor sales and marketing ROI .
  • Liquidity adequate for 12 months: $8.2M cash and ~$9.2M working capital at quarter end, plus $0.6M settlement receivable expected in August; shelf capacity remains available if needed .
  • Non-recurring tailwind: $1.0M litigation proceeds aided Q2 net loss; exclude this when modeling run-rate loss/EBITDA trajectory .
  • Risk/Reward: Regulatory and commercialization milestones could re-rate the story, but execution risk on utilization, EU expansion timing, and MRTP outcomes remains significant .

Citations:

  • Q2 2015 8‑K and Exhibit 99.1 press release:
  • Q2 2015 10‑Q (financials, MD&A, cash flow, balance sheet):
  • Q1 2015 8‑K press release:
  • MAGIC EU launch background (additional context):